Explore Profound Medical's Innovations at Healthcare Investor Conference

Profound Medical's Upcoming Engagement at Healthcare Investor Conference
Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) is set to take the stage at a prestigious healthcare investor conference. This exciting opportunity is expected to showcase the company's latest advancements in medical technology, specifically focusing on their innovative, incision-free therapies designed for treating diseased tissue.
Live Presentation Details
The event will take place at the Metro Toronto Convention Centre, where Profound Medical's management team will provide an update on the company's progress and future direction. Attendees can look forward to a comprehensive presentation outlining how Profound is set to make waves in the medical device landscape. The live broadcast will ensure that interested parties can follow the insights shared during the event. This presentation will be available for later viewing on Profound's official website.
Understanding Profound Medical's Technology
Profound Medical specializes in developing and marketing adaptable, non-invasive therapies. One of their flagship products is TULSA-PRO®, a cutting-edge technology that combines the precision of real-time MRI with ultrasound and intelligent temperature feedback control for effective tissue ablation. The TULSA procedure is designed for a variety of prostate health issues, including cancer treatment and benign prostatic hyperplasia (BPH).
How TULSA-PRO® Works
The TULSA-PRO® system allows for a streamlined treatment option that prioritizes patient well-being. Notably, this procedure is both incision-free and radiation-free, performed in just one session that typically lasts a few hours. By solely focusing on the targeted prostate tissue, it ensures minimal side effects while providing quick recovery times for patients. This method also stands out for its safety and efficiency in treating various prostate shapes and sizes without requiring hospitalization.
Expanding Horizons with Sonalleve®
In addition to TULSA-PRO®, Profound Medical is also pushing boundaries with Sonalleve®, a therapeutic platform approved for treating uterine fibroids and certain bone metastases. This innovative technology is making strides not only in Canada and Europe but also in China, where it has received regulatory approval for non-invasive treatments.
Future Prospects for Sonalleve®
The clinical applications for Sonalleve® are being actively explored, positioning the technology for potential in treating a broader range of conditions, including various abdominal cancers and as a method for hyperthermia in cancer therapy. This exploration underscores Profound's commitment to improving patient outcomes through cutting-edge treatment options.
Company Contact Information
For more details about their technology and upcoming events, Stephen Kilmer from Investor Relations can be reached via email at skilmer@profoundmedical.com, or by phone at 647.872.4849.
Frequently Asked Questions
What is Profound Medical's primary focus?
Profound Medical specializes in developing incision-free therapies for the treatment of diseased tissue.
Where will the presentation take place?
The presentation will be held at the Metro Toronto Convention Centre.
How can I access the presentation?
The presentation will be live-streamed and later archived on Profound Medical's website.
What are TULSA-PRO®'s main benefits?
This technology is known for being safe, effective, and quick in treatment, allowing for a faster recovery without hospitalization.
What approvals does the Sonalleve® platform have?
Sonalleve® is CE marked and has received approval in various regions, including FDA approval for specific treatments.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.